These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26292946)

  • 1. Too Much Medicine: Time to Stop Indiscriminate Cancer Screening.
    Ng RC
    Ann Acad Med Singap; 2015 Jun; 44(6):194-6. PubMed ID: 26292946
    [No Abstract]   [Full Text] [Related]  

  • 2. [A physician not doing too much is favorable for both the patient and the economy].
    Nilsson G
    Lakartidningen; 2013 Sep 25-Oct 8; 110(39-40):1720-1. PubMed ID: 24245425
    [No Abstract]   [Full Text] [Related]  

  • 3. Population based screening - the difficulty of how to do more good than harm and how to achieve it.
    Zwahlen M; Low N; Borisch B; Egger M; Künzli N; Obrist R; Paccaud F; Zybach U; Probst-Hensch NM
    Swiss Med Wkly; 2010; 140():w13061. PubMed ID: 20419512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Principles of Cancer Screening.
    Pinsky PF
    Surg Clin North Am; 2015 Oct; 95(5):953-66. PubMed ID: 26315516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing overdiagnosis: how to stop harming the healthy.
    Moynihan R; Doust J; Henry D
    BMJ; 2012 May; 344():e3502. PubMed ID: 22645185
    [No Abstract]   [Full Text] [Related]  

  • 6. We can learn from disciplines outside medicine.
    Polak L
    BMJ; 2012 Jun; 344():e4293. PubMed ID: 22734093
    [No Abstract]   [Full Text] [Related]  

  • 7. What about the contributions of Illich and Skrabanek?
    Powell DE
    BMJ; 2012 Jun; 344():e4298. PubMed ID: 22734097
    [No Abstract]   [Full Text] [Related]  

  • 8. [Economic impact of lung cancer screening in France: A modeling study].
    Gendarme S; Perrot É; Reskot F; Bhoowabul V; Fourre G; Souquet PJ; Milleron B; Couraud S
    Rev Mal Respir; 2017 Sep; 34(7):717-728. PubMed ID: 26585377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidenced based practice should reduce overdiagnosis and overtreatment.
    Llewelyn H
    BMJ; 2012 Jun; 344():e4296. PubMed ID: 22734095
    [No Abstract]   [Full Text] [Related]  

  • 10. Cancer screening rates in individuals with different life expectancies.
    Royce TJ; Hendrix LH; Stokes WA; Allen IM; Chen RC
    JAMA Intern Med; 2014 Oct; 174(10):1558-65. PubMed ID: 25133746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit cannot be assumed even if clinical trials are positive.
    Connolly CK
    BMJ; 2012 Jun; 344():e4297. PubMed ID: 22734096
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening for prostate cancer: prostate-specific antigen testing is not effective.
    Hitzeman N; Molina M
    Am Fam Physician; 2011 Apr; 83(7):802-4. PubMed ID: 21524045
    [No Abstract]   [Full Text] [Related]  

  • 13. Lung cancer screening gets risk-specific.
    Peres J
    J Natl Cancer Inst; 2013 Jan; 105(1):1-2. PubMed ID: 23257155
    [No Abstract]   [Full Text] [Related]  

  • 14. Transparent risk communication in cancer screening: reveal when it's good and when it's not.
    Wegwarth O
    Oncol Res Treat; 2014; 37 Suppl 3():6-7. PubMed ID: 25195826
    [No Abstract]   [Full Text] [Related]  

  • 15. Decision-making methodology for oral mucosal screening.
    Huff KD; Huff MS
    Dent Today; 2010 May; 29(5):68-71; quiz 71. PubMed ID: 20506912
    [No Abstract]   [Full Text] [Related]  

  • 16. Risks of PSA screening now better understood.
    Peres J
    J Natl Cancer Inst; 2013 Nov; 105(21):1590-2. PubMed ID: 24142893
    [No Abstract]   [Full Text] [Related]  

  • 17. Organised mammographic screening--more benefits than harms.
    Hofvind S
    Tidsskr Nor Laegeforen; 2013 Mar; 133(6):619-20. PubMed ID: 23552154
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for cervical cancer: recommendation statement.
    U.S. Preventive Services Task Force
    Am Fam Physician; 2012 Sep; 86(6):555-9. PubMed ID: 23062047
    [No Abstract]   [Full Text] [Related]  

  • 19. How to Ensure Patient Adherence to Colorectal Cancer Screening and Surveillance in Your Practice.
    Hassan C; Kaminski MF; Repici A
    Gastroenterology; 2018 Aug; 155(2):252-257. PubMed ID: 29964039
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer screening.
    Pierce M
    Am J Nurs; 2001 Oct; 101(10):14. PubMed ID: 11680333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.